Precision BioSciences Inc (NAS:DTIL)
$ 7.29 0.18 (2.53%) Market Cap: 55.92 Mil Enterprise Value: -14.97 Mil PE Ratio: 121.50 PB Ratio: 0.84 GF Score: 59/100

Precision BioSciences Inc Allogeneic CAR T Update- Conference Call Transcript

Jun 08, 2022 / 12:00PM GMT
Release Date Price: $54.6 (-12.92%)
Operator

Good day and thank you for standing by and welcome to the Allogeneic CAR T Update Conference Call. At this, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. (Operator Instructions).

I would now like to hand the conference over to Alex Kelly, Chief Financial Officer. Please, go ahead, sir.

Alex Kelly
Precision BioSciences - Chief Financial Officer

Thank you very much and good morning everyone and welcome to our webcast to discuss the progress that we've made with our allogeneic CAR T programs.

Before we begin, I'd like to remind you that the statements that we make today on the webcast, they do not relate to matters of historical fact, our future expectations and our forward-looking statements. Our forward-looking statements are within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors, including without limitation the risk factors in Precision's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot